These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26321094)

  • 1. Polymeric Nanostructured Systems for Liquid Formulation of Praziquan-tel: Development and in vitro Assessment.
    de Campos VE; Silva JA; Ricci-Júnior E; Mansur CR; Conti DS; da Rocha SR
    Curr Drug Deliv; 2016; 13(2):287-97. PubMed ID: 26321094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and optimization of thermosensitive nanoemulsion hydrogel for sustained-release of praziquantel.
    Cong Z; Shi Y; Peng X; Wei B; Wang Y; Li J; Li J; Li J
    Drug Dev Ind Pharm; 2017 Apr; 43(4):558-573. PubMed ID: 27935330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of flexible and dispersible oral formulations containing praziquantel for potential schistosomiasis treatment of pre-school age children.
    Trastullo R; Dolci LS; Passerini N; Albertini B
    Int J Pharm; 2015 Nov; 495(1):536-550. PubMed ID: 26386139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment.
    de Souza AL; Andreani T; de Oliveira RN; Kiill CP; dos Santos FK; Allegretti SM; Chaud MV; Souto EB; Silva AM; Gremião MP
    Int J Pharm; 2014 Mar; 463(1):31-7. PubMed ID: 24370839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation.
    Nesamony J; Shah IS; Kalra A; Jung R
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1253-63. PubMed ID: 23837519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal evaporation delivery system of praziquantel for schistosomiasis japonicum chemotherapy.
    Wang L; Zheng X; Fang Y; Wang Y; Duan C; Yao B
    J Pharm Sci; 2011 Jul; 100(7):2769-77. PubMed ID: 21319162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of the oral praziquantel anthelmintic effect by cyclodextrin complexation.
    de Jesus MB; Pinto Lde M; Fraceto LF; Magalhães LA; Zanotti-Magalhães EM; de Paula E
    J Drug Target; 2010 Jan; 18(1):21-6. PubMed ID: 19624246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative Bioavailability of Orally Dispersible Tablet Formulations of Levo- and Racemic Praziquantel: Two Phase I Studies.
    Bagchus WM; Bezuidenhout D; Harrison-Moench E; Kourany-Lefoll E; Wolna P; Yalkinoglu O
    Clin Transl Sci; 2019 Jan; 12(1):66-76. PubMed ID: 30536632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyrrhizin-Assisted Transport of Praziquantel Anthelmintic Drug through the Lipid Membrane: An Experiment and MD Simulation.
    Kim AV; Shelepova EA; Selyutina OY; Meteleva ES; Dushkin AV; Medvedev NN; Polyakov NE; Lyakhov NZ
    Mol Pharm; 2019 Jul; 16(7):3188-3198. PubMed ID: 31198045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution and oral bioavailability enhancement of praziquantel by solid dispersions.
    Liu Y; Wang T; Ding W; Dong C; Wang X; Chen J; Li Y
    Drug Deliv Transl Res; 2018 Jun; 8(3):580-590. PubMed ID: 29450806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety.
    Navaratnam AM; Sousa-Figueiredo JC; Stothard JR; Kabatereine NB; Fenwick A; Mutumba-Nakalembe MJ
    Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):400-7. PubMed ID: 22657533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructured Lipid Carriers as a Strategy to Improve the In Vitro Schistosomiasis Activity of Praziquantel.
    Kolenyak-Santos F; Garnero C; de Oliveira RN; de Souza AL; Chorilli M; Allegretti SM; Longhi MR; Chaud MV; Gremião MP
    J Nanosci Nanotechnol; 2015 Jan; 15(1):761-72. PubMed ID: 26328440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability and palatability of praziquantel incorporated into solid-lipid nanoparticles fed to yellowtail kingfish Seriola lalandi.
    Partridge GJ; Rao S; Woolley LD; Pilmer L; Lymbery AJ; Prestidge CA
    Comp Biochem Physiol C Toxicol Pharmacol; 2019 Apr; 218():14-20. PubMed ID: 30543863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatible nanoemulsions based on hemp oil and less surfactants for oral delivery of baicalein with enhanced bioavailability.
    Yin J; Xiang C; Wang P; Yin Y; Hou Y
    Int J Nanomedicine; 2017; 12():2923-2931. PubMed ID: 28435268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipid complex based nanoemulsion system for oral insulin delivery: preparation, in vitro, and in vivo evaluations.
    Hu XB; Tang TT; Li YJ; Wu JY; Wang JM; Liu XY; Xiang DX
    Int J Nanomedicine; 2019; 14():3055-3067. PubMed ID: 31118622
    [No Abstract]   [Full Text] [Related]  

  • 16. Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles.
    Xie S; Pan B; Wang M; Zhu L; Wang F; Dong Z; Wang X; Zhou W
    Nanomedicine (Lond); 2010 Jul; 5(5):693-701. PubMed ID: 20662641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
    Yang L; Geng Y; Li H; Zhang Y; You J; Chang Y
    Pharmazie; 2009 Feb; 64(2):86-9. PubMed ID: 19320279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
    Kumar D; Ali J; Baboota S
    Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment.
    Albertini B; Perissutti B; Bertoni S; Zanolla D; Franceschinis E; Voinovich D; Lombardo F; Keiser J; Passerini N
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30870971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study.
    Mahende MK; Huber E; Kourany-Lefoll E; Ali A; Hayward B; Bezuidenhout D; Bagchus W; Kabanywanyi AM
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0007370. PubMed ID: 34106922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.